Navigation Links
Australia to Show Leniency towards U.S. Pharmaceutical Companies

Australian would remove the amendment which states to reduce the price of the drug obtained from US.

The Trade Minister and the // acting Prime Minister Mark Vaile reported that this amendment was accepted because it was supported by the major opposition party in Australia (Labor Party).

The reason that the party supported the amendment was to prevent the delay in the introduction of new generic drugs.

According to the amendment the Australian authorities have the power to levy heavy fines and ask the pharmaceutical company to reimburse for the lost sales.

Apart from that the company has to pay extra cash to the federal and state government. This amendment became a law and was in function from the first of January 2005.

But the Australian government also considers the risks the pharmaceutical company has to face and has told that this act would be reviewed.

The government told the companies that the act would be removed if the companies proved that the act has been misused by the Australian government.

But still the Australian government still wishes that both the parties discuss on this issue and come out with a better law which would not be detrimental to both the Australian government and the pharmaceutical companies.

He also mentioned that the pharmaceutical companies can delay their patents only if there is an enhancement in the profits due to the drug.

But the government will never allow the misuse of the law at any cost.


'"/>




Page: 1

Related medicine news :

1. Australian Scientists Silence Cancer Gene
2. Australia earmarks $74 Million to Fight Bird Flu
3. Australian Government To Stockpile Anti-Bird Flu Drug Relenza
4. Obesity among The Poor in Australia.
5. Increase In Health Insurance Premium Likely In Australia
6. Australian Company Gets $10 million For Developing Skin Cancer Gel
7. Australian Health funds stand accused
8. Bird flu scare in Australia
9. Australia awaits US FDA reports on ADHD drugs
10. No booster vaccine For every fourth child in Australia
11. Australia Witnesses A Fall In the Number of Organ Donors
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... ... April 25, 2017 , ... ProRehab Physical Therapy ... the preferred physical therapy provider for Derby City CrossFit, effective immediately. , In ... as quickly and effectively as possible, ProRehab’s sports physical therapists will work with ...
(Date:4/25/2017)... ... April 25, 2017 , ... As President Trump ... preparing for how his administration could impact the employee benefits industry. James Slotnick, ... are most likely to make it through Congress. His discussion will focus on ...
(Date:4/25/2017)... , ... April 25, 2017 , ... Lake Park Dental ... by using Invisalign® in Lutz, FL. With the help of this highly-effective, ... aesthetics with fewer potential complications, more discretion and less pain. , Drs. Sarah ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... unveiling cutting-edge birth defects research related to Zika virus during pregnancy, as well ... society for this important science. , The Teratology Society is ...
(Date:4/25/2017)... ... ... MD is committed to providing the highest quality of spine care to all his patients. ... all my patients to alleviate possible future issues. I am pleased to have you as ... my trained staff will assist you in any way possible.” , Dr. Saad Chaudhary is ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... ZappRx, Inc ., a digital health company focused on modernizing ... closed $25 million in Series B funding led by Qiming ... Seattle that is part of a broader ... round included participation from SR One , who led ... (formerly Google Ventures). As part of the financing, Mark ...
(Date:4/20/2017)... April 20, 2017 Eyevensys, a ... first non-viral gene expression technology that enables the safe, ... to address a wide range of ophthalmic diseases, announces ... Healthcare products Regulatory Agency (MHRA) to advance its technology ... ...
Breaking Medicine Technology: